Aclaris Therapeutics Inc (NASDAQ:ACRS)

13.00
Delayed Data
As of May 27
 +0.53 / +4.25%
Today’s Change
9.26
Today|||52-Week Range
24.00
-10.59%
Year-to-Date

Today’s Trading

Previous close12.47
Today’s open12.57
Day’s range12.12 - 13.20
Volume337,318
Average volume (3 months)475,076
Market cap$806.3M
Data as of 05/27/2022

Growth & Valuation

Earnings growth (last year)-33.56%
Earnings growth (this year)+4.79%
Earnings growth (next 5 years)+38.60%
Revenue growth (last year)+4.30%
P/E ratio--
Price/Sales122.00
Price/Book3.76

Competitors

----
CRNXCrinetics Pharmaceut...-0.33-1.93%
KURAKura Oncology Inc+0.96+7.65%
ENTAEnanta Pharmaceutica...+1.34+3.51%
Data as of 3:59pm ET, 05/27/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$6.8M
Annual profit (last year)-$90.9M
Net profit margin-1,343.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Wayne, Pennsylvania

Forecasts